GottliebAB, RyanC, MuraseJE. Clinical considerations for the management of psoriasis in women. Int J Womens Dermatol, 2019; 5:141–150.
2.
MaulJT, AnzengruberF, ConradC, et al.Topical treatment of psoriasis vulgaris: The Swiss treatment pathway. Dermatology, 2021; 237:166–178.
3.
Fischer-BetzR, ØstensenM. Biologics and small molecules in the management of psoriatic arthritis: Reproduction related issues in female and male patients. Expert Rev Clin Pharmacol, 2021; 14:979–989.
4.
SmithCH, YiuZZN, BaleT, et al.British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: A rapid update. Br J Dermatol, 2020; 183:628–637.
5.
BelinchónI, VelascoM, Ara-MartínM, et al.[Management of psoriasis during preconception, pregnancy, postpartum, and breastfeeding: A consensus statement]. Actas Dermosifiliogr (Engl Ed), 2021; 112:225–241.
6.
ThatiparthiA, MartinA, LiuJ, et al.Biologic treatment algorithms for moderate-to-severe psoriasis with comorbid conditions and special populations: A review. Am J Clin Dermatol, 2021; 22:425–442.
7.
NotiA, GrobK, BiedermannM, et al.Exposure of babies to C(15)-C(45) mineral paraffins from human milk and breast salves. Regul Toxicol Pharmacol, 2003; 38:317–325.
8.
De StefanoP, BongoIG, Borgna-PignattiC, et al.Factitious hypertension with mineralocorticoid excess in an infant. Helv Paediatr Acta, 1983; 38:185–189.
9.
AndersonPO. Monoclonal antibodies during breastfeeding. Breastfeed Med, 2021; 16:591–593.
